Mattern J - Search Results

1

Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: relationship to various biological factors.

Volm M, Mattern J, Koomagi R. Volm M, et al. Among authors: mattern j. Int J Oncol. 1998 Nov;13(5):975-9. doi: 10.3892/ijo.13.5.975. Int J Oncol. 1998. PMID: 9772289

2

Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits.

Volm M, Mattern J. Volm M, et al. Among authors: mattern j. Carcinogenesis. 1992 Nov;13(11):1947-50. doi: 10.1093/carcin/13.11.1947. Carcinogenesis. 1992. PMID: 1330347

3

Elevated expression of thymidylate synthase in doxorubicin resistant human non small cell lung carcinomas.

Volm M, Mattern J. Volm M, et al. Among authors: mattern j. Anticancer Res. 1992 Nov-Dec;12(6B):2293-6. Anticancer Res. 1992. PMID: 1338282 Clinical Trial.

4

Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.

Volm M, Efferth T, Mattern J. Volm M, et al. Among authors: mattern j. Anticancer Res. 1992 Jan-Feb;12(1):11-20. Anticancer Res. 1992. PMID: 1348920

5

Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170, and glutathione S-transferase-pi in human lung tumors.

Volm M, Mattern J, Samsel B. Volm M, et al. Among authors: mattern j. Cancer. 1992 Aug 15;70(4):764-9. doi: 10.1002/1097-0142(19920815)70:4<764::aid-cncr2820700408>3.0.co;2-m. Cancer. 1992. PMID: 1353700

6

Expression of several resistance mechanisms in untreated human kidney and lung carcinomas.

Volm M, Mattern J, Efferth T, Pommerenke EW. Volm M, et al. Among authors: mattern j. Anticancer Res. 1992 Jul-Aug;12(4):1063-7. Anticancer Res. 1992. PMID: 1354430

7

Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors.

Efferth T, Mattern J, Volm M. Efferth T, et al. Among authors: mattern j. Oncology. 1992;49(5):368-75. doi: 10.1159/000227075. Oncology. 1992. PMID: 1356260

8

Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.

Volm M, Mattern J, Samsel B. Volm M, et al. Among authors: mattern j. Br J Cancer. 1991 Oct;64(4):700-4. doi: 10.1038/bjc.1991.384. Br J Cancer. 1991. PMID: 1680367 Free PMC article.

9

Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.

Volm M, Drings P, Kleine W, Mattern J. Volm M, et al. Among authors: mattern j. Strahlenther Onkol. 1987 Dec;163(12):791-4. Strahlenther Onkol. 1987. PMID: 2827331

10

Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.

Volm M, Hahn EW, Mattern J, Müller T, Vogt-Moykopf I, Weber E. Volm M, et al. Among authors: mattern j. Cancer Res. 1988 May 15;48(10):2923-8. Cancer Res. 1988. PMID: 2834052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters